Alexander Kutikov MD, FACS
Chief, Division of Urology and Urologic Oncology, Roberta R. Scheller Chair in Urologic Oncology, and Professor of Surgical Oncology, Fox Chase Cancer Center; Professor, Lewis Katz School of Medicine at Temple University, Philadelphia, PennsylvaniaDr. Kutikov is a board certified, academic urologic surgical oncologist, who treats tumors of the adrenal, kidney, prostate, bladder, ureter, testis, and other genitourinary organs, using minimally invasive (robotic/laparoscopic) and traditional surgical techniques.
Dr. Kutikov's current research interests include understanding renal/prostatic carcinogenesis, risk-stratification of surgical outcomes, and quantification of competing risks: http://www.fccc.edu/research/pid/kutikov/pub.html
Recent Contributions to PracticeUpdate:
- Impact of Metastasectomy on Cancer-Specific and Overall Survival in Metastatic Renal Cell Carcinoma
- Stereotactic Radiotherapy and Short-Course Pembrolizumab for Oligometastatic Renal Cell Carcinoma
- Adrenalectomy During Radical Nephrectomy Does Not Improve Survival
- Posterior Retroperitoneoscopic Adrenalectomy in the US
- Patient Factors Predict Complications After Partial Nephrectomy
- Risk Factors for Peritoneal Carcinomatosis Following Open Radical Cystectomy
- Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism
- Close Proximity to the Collecting System Increases Risk of Malignancy in Small Renal Tumors
- Incidence of Visible Hematuria Among Antithrombotic Agents
- Robot-Assisted Adrenalectomy vs Open Adrenalectomy